Publication Name	World Journal of Methodology
Manuscript ID	84619
Country	India

Received	2023-03-22 16:07
Peer-Review Started	2023-03-22 16:09
To Make the First Decision
Return for Revision	2023-04-17 18:46
Revised	2023-05-02 20:16
Second Decision	2023-05-31 03:10
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-05-31 08:02
Articles in Press	2023-05-31 08:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-06-13 07:24
Publish the Manuscript Online	2023-06-20 11:28

ISSN	2222-0682 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Evolving utility of exosomes in pancreatic cancer management
Manuscript Source	Invited Manuscript
All Author List	Thattungal Manoharan Anoop, Palash Kumar Basu, K Chandramohan, Ajai Thomas and S Manoj
ORCID	Author(s) ORCID Number Thattungal Manoharan Anoop http://orcid.org/0000-0003-0567-5253
Funding Agency and Grant Number
Corresponding Author	Thattungal Manoharan Anoop, DNB, FRCP, MBBS, MD, Associate Professor, Department of Medical Oncology, Regional Cancer Center, Medical College Campus, Kumarapuram Road, Thiruvananthapuram 695011, Kerala, India. dranooptm@yahoo.co.in
Key Words	Pancreatic cancer; Exosomes; Biomarker; Liquid biopsy; Clinical applications; Circulating biomarkers
Core Tip	The determination and identification of biomarkers using liquid biopsy can enable the early detection, monitoring, therapeutic interventions, risk of relapse, therapeutic targets and identification of resistance mechanisms in pancreatic cancer (PC). There has been a recent interest in use of exosomes as biomarker in PC management. Exosomes loaded with multiple diagnostic molecules can be isolated from different body fluids and can be used for making the exosome markers-based liquid biopsy more attractive for initial tumor detection, monitoring, and prognostic assessment of PC.
Publish Date	2023-06-20 11:28
Citation	Anoop TM, Basu PK, Chandramohan K, Thomas A, Manoj S. Evolving utility of exosomes in pancreatic cancer management. World J Methodol 2023; 13(3): 46-58
URL	https://www.wjgnet.com/2222-0682/full/v13/i3/46.htm
DOI	https://dx.doi.org/10.5662/wjm.v13.i3.46

Full Article (PDF)	WJM-13-46-with-cover.pdf
Full Article (Word)	WJM-13-46.docx
Manuscript File	84619_Auto_Edited-JLW.docx
Answering Reviewers	84619-Answering reviewers.pdf
Audio Core Tip	84619-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	84619-Conflict-of-interest statement.pdf
Copyright License Agreement	84619-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	84619-Language certificate.pdf
Peer-review Report	84619-Peer-review(s).pdf
Scientific Misconduct Check	84619-Bing-Chen YL-2.png
Scientific Editor Work List	84619-Scientific editor work list.pdf